Who travels for stem cell therapy — and why

Searches for "stem cell abroad" have tripled since 2023, driven by orthopaedic and neurological cases, with savings of 40–80%. Relative demand by source market:

Relative demand index by source market

United States90

United Kingdom78

Gulf (UAE/KSA/Qatar)70

Germany62

Canada55

Israel40

Scandinavia/NL35

China/East Asia48

Why they travel

USA — most therapies remain experimental under the FDA; patients save 40–80%.
UK — limited availability and long private waits.
Gulf — high willingness to pay, family-led care, fast medical visas.
Germany — same EU quality at home costs €15–35k; Bulgaria is the price-shock alternative.

Relative index (illustrative), based on 2025–26 medical-tourism reporting.

Terapie celulară de nivel european, fără prețuri europene.

Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.

Evaluare medicală gratuită

Who travels for stem cell therapy — and why

Why they travel

For these patients

Terapie celulară de nivel european, fără prețuri europene.